跳转至内容
Merck
CN

DOPA1003

Dopaminergic neurons, PARK7 (-/-) KO Line

IPSC derived

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

human

growth mode

Adherent

karyotype

2n=46

morphology

elongated/polarized, neuronal

relevant disease(s)

Parkinson′s disease

shipped in

dry ice

storage temp.

−196°C

Application

These products provide unique and versatile tools for the study of central nervous system (CNS) disorders, such as Alzheimer′s disease (AD), Parkinson′s disease (PD), autism, schizophrenia, and amyotrophic lateral sclerosis (ALS), as well as for drug screening and toxicology applications in the neural space.

Biochem/physiol Actions

biallelic knock-out of PARK7 gene

Features and Benefits

This product contains cryo-preserved, pre-differentiated dopaminergic neurons derived from a footprint-free, karyotype normal human iPSC line with a homozygous knockout in PARK7 made using zinc fingers. It is designed for customers to generate mature dopaminergic neurons using the optimized maturation medium and supplements (DOPA1050, DOPA1051 sold separately). Mature and functional dopaminergic neurons can be obtained within 12-14 days. The dopaminergic precursors can be seeded on various culture vessel formats including 96-well plates on either glass or plastic surfaces and cultured as adherent cells. Shortly after seeding, the cells proliferate slightly for up to 4 days and show extensive neurite outgrowth and proper neuronal morphology. In general, at 12-14 days post-seeding, the cell population will contain >80% neurons, >30% TH+ dopaminergic neurons and < 15% GFAP+ astrocytes.

Preparation Note

No subculture routine is necessary. See technical bulletin for additional details.
User must also purchase Dopa Maturation Medium, DOPA1050 (50mL) or DOPA1051 (250mL). Sold separately.

存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Andrzej Swistowski et al.
Stem cells (Dayton, Ohio), 28(10), 1893-1904 (2010-08-18)
Human induced pluripotent stem cells (iPSCs) reprogrammed from somatic cells represent a promising unlimited cell source for generating patient-specific cells for biomedical research and personalized medicine. As a first step, critical to clinical applications, we attempted to develop defined culture
Yiping Yan et al.
Stem cells translational medicine, 2(11), 862-870 (2013-10-12)
Human pluripotent stem cells (hPSCs), including human embryonic stem cells and human induced pluripotent stem cells, are unique cell sources for disease modeling, drug discovery screens, and cell therapy applications. The first step in producing neural lineages from hPSCs is

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持